Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Factors affecting adherence
Factors associated with antipsychotic-induced pneumonia
fasting plasma glucose (FPG) test
Fatal Toxicity Index (FTI), antidepressants
Fatigue psychostimulants to reduce in depression multiple sclerosis
Ferritin in blood, psychotropic agent effects
Findings of meta-analyses of the risk of pathological blood clotting
First-Episode Schizophrenia
Fish oils dyslipidaemia treatment mild/moderate depressions in older adults
Fixed-dose regimens, benzodiazepines for alcohol withdrawal management
Flow chart for the use of covert medication.
Flumazenil Acutely disturbed or violent behaviour induction by antidepressants
Flumazenil, guidelines for use of
Fluoxetine autism spectrum disorder borderline personality disorder depression/bipolar disorder suicidality in children and adolescents bipolar depression bulimia nervosa in pregnancy
Flupentixol borderline personality disorder pharmacokinetics bipolar disorder long-acting injections doses and frequencies
Fluxoxamine for antipsychotic-induced weight gain smokers for tardive dyskinesia
forms T4/T5/T6, Mental Health Act
Factors affecting postmortem blood concentrations
Family, improving medication adherence
Fatal Toxicity Index
Fentanyl dependence, buprenorphine low-dose induction
Financial incentives, improving adherence
First-choice agents prescribed for tardive dyskinesia (αbetical order; no preference implied)
first-generation antipsychotics (FGAs)
Flowchart for naloxone administration.
Fluid restriction, hyponatraemia treatment
flunitrazepam, concentration in normal dosing and UK legal limit
Fluphenazine, smokers
forms T2 and T3, Mental Health Act
Formulations of drugs impaired absorption following bariatric surgery problems with tablets when tapering